Superficial Basal Cell Carcinoma

Superficial Basal Cell Carcinoma is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Classified under: Neoplasms
Skin and Subcutaneous Tissue Diseases
Urogenital Neoplasms
Indicated drugs: Aminolevulinic acid
Fluorouracil
Imiquimod

Resolves to

Vocabularies

SNOMED CT254701007MedDRA10004146UMLSC0334256

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

13Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Superficial Basal Cell Carcinoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.